Assessment of a combination screening assay for celiac disease

Autoimmunity Highlights

Table 3 Positive subjects for each parameter analyzed in the subgroup of disease controls

	Total cases	IgA a-tTG^a	IgG a- tTG^a	IgA EMA^a	Iga a-DGP^a	IgG a-DGP^a	h-tTG/DGP Screen^a
Patients with autoimmune hepatopathies	15	0/15	2/15	0/15	0/15	0/15	0/15
Patients with autoimmune hepatopathies	15	0%	13.33%	0%	0%	0%	0%
Patients with hepatitis/cirrhosis	12	1/12	3/12	0/12	1/12	0/12	1/12
Patients with hepatitis/cirrhosis	12	8.33%	25.00%	0%	8.33%	0%	8.33%
Patients with viral hepatitis/cirrhosis	35	1/35	6/35	0/35	0/35	0/35	1/35
Patients with viral hepatitis/cirrhosis	35	2.85%	17.14%	0%	0%	0%	2.85%
Patients with other gastrointestinal diseases	83	0/83	18/83	0/83	4/83	7/83	12/83
Patients with other gastrointestinal diseases	83	0%	21.68%	0%	4.81%	8%	14.45%

^aPositivity is expressed as number of positive cases/total number of cases and as % of positive cases

ISSN: 2038-3274